搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
FierceBiotech
8 天
Merus' head and neck cancer candidate bolsters 'best-in-disease' profile with new data drop ...
With new data on petosemtamab set to be presented at the European Society for Medical Oncology Asia Congress, Merus believes ...
HealthDay on MSN
15 小时
Radiotherapy With Adjuvant Durvalumab No Benefit for Head, Neck Cancer
For patients with locoregionally advanced head and neck squamous cell carcinoma (HNSCC) with a contraindication for cisplatin ...
Dunya News
4 天
Study links air pollution to head, neck cancer risk
(Web Desk) - The harmful effects of air pollution on health, including an increased risk of cancer, have been well-documented ...
BlackDoctor
7 天
A Clinical Trial Found a Cisplatin Alternative for Head-and-Neck Cancers
A new trial finds that cetuximab outperforms durvalumab as a second-line treatment in patients who cannot tolerate cisplatin.
4 天
on MSN
Opioids interfere with cancer immunotherapy, but another type of drug could help
Opioids are often first-line treatments for cancer-related pain, but they can suppress the immune system and reduce the ...
Taiwan News
9 天
Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at ...
Application error: a client-side exception has occurred (see the browser console for more information).
10 小时
Merus Positioned for Growth Amid Promising Clinical Data and Resilience to Market Fluctuations
Leerink Partners analyst Andrew Berens has maintained their bullish stance on MRUS stock, giving a Buy rating yesterday.Pick the best stocks ...
4 天
Promising Potential of Bicara Therapeutics’ Ficerafusp Alfa: A Buy Rating Supported by ...
Bicara Therapeutics Inc. (BCAX) has received a new Buy rating, initiated by H.C. Wainwright analyst, Robert Burns.Don't Miss our Black Friday ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈